News

Government makes €20M available for NWA

- De minister en de staatssecretaris van OCW stellen 20 miljoen beschikbaar voor de Nationale Wetenschapsagenda. Deze startimpuls is verbonden aan drie thema’s op het gebied van veerkrachtige samenlevingen, digitalisering en de bijdrage van natuurwetenschappelijke kennis aan vernieuwing. De Kenniscoalitie, verantwoordelijk voor de ontwikkeling van de NWA, werkt nu hard het opzetten van een goede procedure voor het inzetten van deze 20 miljoen.

Governance wants to bring European Medicines Agency to the Netherlands

- Nederland stelt zich kandidaat voor de vestiging van het Europese geneesmiddelenagentschap EMA (European Medicines Agency). De ministers Edith Schippers (VWS) en Bert Koenders (Buitenlandse Zaken) hebben de Tweede Kamer vandaag namens het kabinet over de kandidaatsstelling geïnformeerd.

Drug access platform myTomorrows raises €10m

- Octopus Ventures and EQT Ventures invest to improve access to drugs in development for physicians and patients.

Orchard Therapeutics Announces a Manufacturing Alliance with PharmaCell B.V.

- Orchard Therapeutics (“Orchard”), a clinical-stage biotechnology company dedicated to bringing transformative ex-vivo gene therapies to patients with serious and life-threatening orphan diseases announces an alliance with PharmaCell B.V. (“PharmaCell”), a leading Contract Manufacturing Organization (CMO) for Cell and Gene Therapies and Regenerative Medicine.

HUB and Dutch Health Insurance Companies to Validate Use of Organoids for Cystic Fibrosis

- Hubrecht Organoid Technology (HUB), and the health insurance companies CZ, Zilveren Kruis, and Menzis announced that they will start a €3 million validation trial for use of HUB Organoid Technology to test if it can be used to determine the response of Cystic Fibrosis (CF) patients to new drug therapies.

Incyte and Merus Announce Global Strategic Research Collaboration to Discover and Develop Bispecific Antibodies

- Incyte Corporation and Merus N.V. announced that they have entered into a global, strategic collaboration agreement focused on the research, discovery and development of bispecific antibodies utilizing Merus’ proprietary Biclonics® technology platform.

TNO publish report on Public-Private Partnerships

- Vandaag heeft minister Kamp van Economische Zaken uit handen van Paul de Krom, CEO van TNO de publicatie De Staat van Nederland Innovatieland 2016 (SNI2016) ontvangen.

Dutch start-up Core Life Analytics to rescue scientists who are drowning in data.

- Utrecht technology start-up, Core Life Analytics BV, has on December 19th 2016, signed an agreement with the UMC Utrecht for exclusive rights to commercialize HC StratoMineR, a data analytics platform developed at the UMCU.

Are you active in the United States and want to help?

- In 2017, special attention will be paid to the health sector in the United States and its opportunities for the Dutch Life Sciences & Health (LSH) sector. Are you active in the US and want to help by answering a short survey?

Health~Holland Update November 2016

- In this edition, we provide an update on the Venture Challenge winner, new National Icons, deadlines for the Match Call in 2017, and the second Create Health call. We are proud to present the new Life Sciences education roadmap and we highlight two public-private partnerships. Finally, we shed light on some national and international events and missions.